ANDREWS DEBORAH J 4

What Happened
Deborah J. Andrews, serving as Interim Co-Chief Executive Officer and Chief Financial Officer of STAAR Surgical Co. (STAA), received an award of 20,787 restricted stock units (RSUs) on February 2, 2026. The RSUs were granted at $0.00 (reported value $0 on the Form 4) and are a derivative award that converts to common shares upon vesting. The filing notes the grant was made in connection with her appointment as Interim Co-CEO.

Key Details

• Transaction date: February 2, 2026; Form 4 filed February 4, 2026 (filed timely).
• Transaction type/code: Award/Grant (A) — 20,787 RSUs granted at $0.00 (derivative).
• Vesting: 100% of the RSUs vest on August 1, 2026 (per footnote).
• Footnotes: F1 — each RSU equals the right to receive one share upon vesting; F2 — RSUs granted Feb 2, 2026, vesting Aug 1, 2026.
• Shares owned after the transaction: not disclosed in the provided filing.

Context
RSUs are compensation awards, not open‑market purchases or sales; they become shares only if and when they vest. Such grants are commonly used to align executive pay with shareholder interests and can reflect standard onboarding or promotion-related compensation rather than a direct signal about the insider’s view of the stock.